{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:17:53Z","timestamp":1792793873538,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.humpath.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T05:25:35Z","timestamp":1717910735000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Acquired cystic disease associated renal cell carcinoma: A clinicopathologic and molecular study of 31 tumors"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1719-2451","authenticated-orcid":false,"given":"Ejas","family":"Palathingal Bava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Sanfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alkashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Favazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Aldilami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed T.","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-8751","authenticated-orcid":false,"given":"Khaleel I.","family":"Al-Obaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.06.002_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib2","doi-asserted-by":"crossref","first-page":"2022\/03","DOI":"10.3390\/biomedicines10030657","article-title":"Renal cell carcinoma in end-stage renal disease: a review and update","volume":"10","author":"El-Zaatari","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.humpath.2024.06.002_bib3","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.21037\/tau-20-1150","article-title":"Towards a new WHO classification of renal cell tumor: what the clinician needs to know-a narrative review","volume":"10","author":"Cimadamore","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.humpath.2024.06.002_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jmoldx.2016.07.012","article-title":"Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays","volume":"19","author":"Kadri","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2024.06.002_bib5","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41379-021-00833-7","article-title":"EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma","volume":"34","author":"Al-Obaidy","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib6","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2024.06.002_bib7","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/bioinformatics\/btu376","article-title":"ABRA: improved coding indel detection via assembly-based realignment","volume":"30","author":"Mose","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2024.06.002_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the association for molecular Pathology, American society of clinical oncology, and college of American pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2024.06.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.humpath.2024.06.002_bib10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/PAS.0000000000001255","article-title":"Genetic underpinnings of renal cell carcinoma with leiomyomatous stroma","volume":"43","author":"Parilla","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1101\/gr.221028.117","article-title":"SvABA: genome-wide detection of structural variants and indels by local assembly","volume":"28","author":"Wala","year":"2018","journal-title":"Genome Res"},{"key":"10.1016\/j.humpath.2024.06.002_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gcc.22860","article-title":"Sclerosing TSC1 mutated renal cell carcinoma: an unusual pattern mimicking MITF family translocation renal cell carcinoma","volume":"59","author":"Williamson","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2024.06.002_bib13","first-page":"137","article-title":"[International society of urological Pathology (ISUP) vancouver classification of renal neoplasia 2012]","volume":"50","author":"Hes","year":"2014","journal-title":"Cesk Patol"},{"key":"10.1016\/j.humpath.2024.06.002_bib14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/PAS.0000000000001482","article-title":"Comprehensive clinicopathologic analyses of acquired cystic disease-associated renal cell carcinoma with focus on adverse prognostic factors and metastatic lesions","volume":"44","author":"Kojima","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.pas.0000152131.58492.97","article-title":"Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study","volume":"29","author":"Sule","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.5858\/arpa.2016-0123-RS","article-title":"Acquired cystic disease-associated renal cell carcinoma: review of pathogenesis, morphology, ancillary tests, and clinical features","volume":"141","author":"Foshat","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2024.06.002_bib19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/PAS.0000000000001530","article-title":"Acquired cystic kidney disease-associated renal cell carcinoma (ACKD-RCC) harbor recurrent mutations in KMT2C and TSC2 genes","volume":"44","author":"Shah","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2559.2009.03361.x","article-title":"Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma","volume":"55","author":"Pan","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.06.002_bib18","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/PAS.0000000000001091","article-title":"Acquired cystic disease-associated renal cell carcinoma (ACD-RCC): a multiinstitutional study of 40 cases with clinical follow-up","volume":"42","author":"Przybycin","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5114\/pjp.2017.73926","article-title":"Acquired cystic disease-associated renal cell carcinoma: a clinicopathological study of seven cases","volume":"68","author":"Kuroda","year":"2017","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00795-010-0496-1","article-title":"Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study","volume":"44","author":"Kuroda","year":"2011","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.humpath.2024.06.002_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00795-009-0465-8","article-title":"Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y","volume":"43","author":"Kuroda","year":"2010","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.humpath.2024.06.002_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.humpath.2009.09.022","article-title":"Oligoarray comparative genomic hybridization of renal cell tumors that developed in patients with acquired cystic renal disease","volume":"41","author":"Kuntz","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/hupa.2002.125370","article-title":"Atypical epithelial proliferations in acquired renal cystic disease harbor cytogenetic aberrations","volume":"33","author":"Cheuk","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib25","article-title":"Genomic features of renal cell carcinoma developed during end-stage renal disease and dialysis","author":"Johnson","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"2022\/07\/28","key":"10.1016\/j.humpath.2024.06.002_bib26","article-title":"SMARCB1-Deficient cancers: novel molecular insights and therapeutic vulnerabilities","volume":"14","author":"Cooper","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.06.002_bib27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44161","article-title":"Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition","volume":"8","author":"Hong","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.humpath.2024.06.002_bib43","doi-asserted-by":"crossref","unstructured":"Agaimy A. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol 2014; 21: 394-410. 2014\/10\/10. DOI: 10.1097\/PAP.0000000000000038.","DOI":"10.1097\/PAP.0000000000000038"},{"key":"10.1016\/j.humpath.2024.06.002_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12920-015-0103-3","article-title":"Integrated genomics has identified a new AT\/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors","volume":"8","author":"Ho","year":"2015","journal-title":"BMC Med Genom"},{"key":"10.1016\/j.humpath.2024.06.002_bib41","doi-asserted-by":"crossref","unstructured":"Gupta S, Albertson D, Gaston D, et al. Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clin Genitourin Cancer 2018; 16: e373-e382. 2017\/10\/05. DOI: 10.1016\/j.clgc.2017.09.001.","DOI":"10.1016\/j.clgc.2017.09.001"},{"key":"10.1016\/j.humpath.2024.06.002_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/cas.13173","article-title":"Oncogenic roles of SMARCB1\/INI1 and its deficient tumors","volume":"108","author":"Kohashi","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2024.06.002_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/10668969241228295","article-title":"Recurrent MTOR mutations in renal cell carcinoma with fibromyomatous stroma: a report of 2 tumors","author":"Palathingal","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.06.002_bib31","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.2147\/CMAR.S315511","article-title":"Targeting Notch4 in cancer: molecular mechanisms and therapeutic perspectives","volume":"13","author":"Xiu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.humpath.2024.06.002_bib32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.urolonc.2012.08.021","article-title":"Kidney cancer","volume":"30","author":"Linehan","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2024.06.002_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/CEJ.0000000000000587","article-title":"SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer","volume":"29","author":"Kumari","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.humpath.2024.06.002_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12032-018-1085-8","article-title":"A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors","volume":"35","author":"Shailani","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2024.06.002_bib35","first-page":"3441","article-title":"Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence","volume":"58","author":"Morimatsu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2024.06.002_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/gcc.10148","article-title":"Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice","volume":"36","author":"Donoho","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2024.06.002_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/0008-5472.417.65.2","article-title":"Functional evaluation and cancer risk assessment of BRCA2 unclassified variants","volume":"65","author":"Wu","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2024.06.002_bib38","doi-asserted-by":"crossref","first-page":"22635","DOI":"10.1002\/jcp.28829","article-title":"Calcium-activated nucleotidase 1 silencing inhibits proliferation, migration, and invasion in human clear cell renal cell carcinoma","volume":"234","author":"Liu","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.humpath.2024.06.002_bib39","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1080\/21655979.2021.2003131","article-title":"Calcium-activated nucleotides 1 (CANT1)-driven nuclear factor-k-gene binding (NF-kB) signaling pathway facilitates the lung cancer progression","volume":"13","author":"Gao","year":"2022","journal-title":"Bioengineered"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:04:19Z","timestamp":1720994659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"alternative-id":["S0046817724001035"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.06.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired cystic disease associated renal cell carcinoma: A clinicopathologic and molecular study of 31 tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}